Advertisement
| anti gd2 therapy neuroblastoma: Progress in Clinical and Biological Research George J. Brewer, 1975 |
| anti gd2 therapy neuroblastoma: Neuroblastoma Swapan K. Ray, 2019-01-17 Neuroblastoma: Molecular Mechanisms and Therapeutic Interventions comprehensively reviews current concepts in molecular and histopathological mechanisms that influence the growth of human malignant neuroblastoma, along with exciting therapeutic interventions. This book features a broad collection of contributions from leading investigators in histopathology, molecular mechanisms, genetics, epigenetics, microRNAs, proteomics, and metabolism in controlling growth and death in neuroblastoma. Recent developments in therapeutic interventions for neuroblastoma are also covered extensively, including chapters on surgery, chemotherapy, targeted therapy and immunotherapy. This book is ideal for advanced undergraduate students, graduate students, medical students, postdoctoral fellows, and investigators with an interest in current molecular concepts and therapeutic interventions. |
| anti gd2 therapy neuroblastoma: Atlas of Pediatric Surgery Ahmed H. Al-Salem, 2020-01-02 This book provides a practical guide to the congenital and acquired problems related to pediatric surgery and urology. A range of topics are covered, including; abdominal wall hernias, hemangioma and vascular malformations, gastrochesis, achalasia, congenital gastric outlet obstruction, renal and liver tumors, intestinal malrotation, and hydronephrosis. The book aims to be a quick reference text for the diagnosis and treatment of pediatric surgery conditions and presents information relevant to general surgeons, pediatricians, pediatric surgeons, and medical trainees. |
| anti gd2 therapy neuroblastoma: Neuroblastoma Sabine Sarnacki, Luca Pio, 2019-08-12 This book addresses neuroblastoma, a type of embryonic tumor derived from neural crest cells and one of the most frequent extra-cranial solid tumors in children. However, the term also describes a heterogeneous group of tumors, the prognosis of which can differ greatly according to age, stage and biology. Some forms undergo spontaneous regression, and some are cured by surgery alone or after chemo-reduction, while others exhibit extremely aggressive behavior. Their successful treatment is one of the best examples of tailored medicine, which involves close collaboration between pediatric surgeons, pediatric oncologists, radiologists, nuclear medicine specialists, biologists, oncogeneticists and radiotherapists. The book pursues a unique approach, as it combines most essential insights from all of these fields, together with key information regarding epidemiology, physiopathology and palliative care. The respective chapters were written by the leading international experts on neuroblastoma, and present the latest advances in terms of research, surgical approaches and medical treatments. The book offers an invaluable resource to all pediatric surgeons, pediatricians, oncologists, students, researchers and all others involved in neuroblastoma management who want to benefit from their colleagues’ expertise. |
| anti gd2 therapy neuroblastoma: Elsevier's 2022 Intravenous Medications - E-Book Shelly Rainforth Collins, 2021-04-16 Find the essential information you need to safely administer more than 400 intravenous drugs! For more than 45 years, Gahart’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for comprehensive drug coverage, unparalleled accuracy, and an intuitive quick-access format. In addition to updated drug interactions, precautions, alerts, and patient teaching instructions for all existing IV drugs, the 2022 edition includes approximately 10 new monographs of the most recent IV drugs to be approved by the FDA. Administering intravenous drugs is a critical task — inaccurate or out-of-date information is not an option. Known as the #1 IV drug handbook on the market, and with its history of impeccable accuracy, Gahart’s annual publication gives you the extra confidence and guidance you need to safely and effectively treat patients. Monographs on more than 400 IV drugs offer an impressive breadth of coverage that goes well beyond any comparable drug reference. Updated annual publication prevents you from referencing outdated information. Additional drug monographs are provided on the companion Evolve website. 45-year history of impeccable accuracy reinforces the importance of safe IV drug administration. Perfect depth of information equips you with everything that is needed for safe administration of IV drugs — nothing more, nothing less. Proven, clinically optimized format keeps all dosage information for each drug on either a single page or a two-page spread to prevent hand contamination by having to turn a page. Highlighted Black Box Warnings and relevant content make locating critical information fast and easy. Special circumstances in blue-screened text call attention to important circumstances that may not warrant Black Box Warnings. Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients. Dilution and dosage charts within monographs provide quick access to essential clinical information. Convenient, alphabetical format organizes all drug monographs by generic name, allowing you to find any drug in seconds. NEW! Drug monographs for newly approved drugs by the FDA provide you with the most current drug information. Updates on drug interactions, precautions, alerts, and more have been made throughout the guide to reflect all changes to existing medications. |
| anti gd2 therapy neuroblastoma: Safety of Biologics Therapy Brian A. Baldo, 2016-08-12 This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters. It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind, Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences. |
| anti gd2 therapy neuroblastoma: Lipid Nanocarriers for Drug Targeting Alexandru Mihai Grumezescu, 2018-04-16 Lipid Nanocarriers for Drug Targeting presents recent advances in the area of lipid nanocarriers. The book focuses on cationic lipid nanocarriers, solid lipid nanocarriers, liposomes, thermosensitive vesicles, and cubosomes, with applications in phototherapy, cosmetic and others. As the first book related to lipid nanocarriers and their direct implication in pharmaceutical nanotechnology, this important reference resource is ideal for biomaterials scientists and those working in the medical and pharmaceutical industries that want to learn more on how lipids can be used to create more effective drug delivery systems. - Highlights the most commonly used types of lipid nanocarriers and explains how they are applied in pharmacy - Shows how lipid nanocarriers are used in different types of treatment, including oral medicine, skin repair and cancer treatment - Assesses the pros and cons of using different lipid nanocarriers for different therapies |
| anti gd2 therapy neuroblastoma: Pediatric Radiation Oncology Thomas E. Merchant, Rolf-Dieter Kortmann, 2018-12-22 This book presents the most up-to-date and innovative information on the targeting and treatment of a wide range of childhood cancers by means of radiation therapy. Written by global experts in pediatric radiation oncology, it documents in detail the treatment regimens appropriate to each disease, highlighting the recent advances that promise to improve rates of survival and cure. The use of image-guided and intensity-modulated radiation therapy is clearly described, and careful attention is also devoted to the roles of proton therapy, stereotactic radiosurgery, stereotactic fractionated radiosurgery, and modulated arc radiotherapy. Separate chapters address localization and verification procedures and anesthesia; pediatric radiation oncology in the palliative care setting; and aspects that are especially relevant in low- and medium-income countries. Beyond clinical radiation oncology, relevant information is provided on radiation physics. The book concludes by examining future directions in the field. |
| anti gd2 therapy neuroblastoma: Progressive Neuroblastoma H. Christiansen, N.M. Christiansen, 2015-09-28 Neuroblastoma is a tumor derived from the sympathetic nervous system. It is the most common extracranial solid tumor occurring in children and exhibits a marked variability in outcome when the disease is categorized by clinical (e.g. age or stage) and biologic characteristics. This book gives an introduction into the clinical features of progressive neuroblastoma and focuses on molecular-targeted therapies and immunotherapies of this disease. It has become increasingly clear that MYCN (v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog) holds a key position in neuroblastic transformation and gene expression in normal and transformed cells. In the 14 chapters important topics such as genomic alterations in neuroblastoma and strategies for indirect molecular targeting of MYCN are discussed. Two chapters, for example, review apoptotic pathways and proapoptotic molecular targets in neuroblastoma, one focusing on the p53 pathway and the extrinsic and intrinsic pathways of apoptosis. Other chapters cover topics related to immunology in neuroblastoma, such as immune regulation in neuroblastoma, immunotherapy related to passive and active vaccination approaches and additional immunotherapy in the treatment of progressive disease. This volume will be essential reading for all clinicians and basic researchers who are involved in delivering health care to patients with progressive neuroblastoma. |
| anti gd2 therapy neuroblastoma: Nuclear Oncology H. William Strauss, Giuliano Mariani, Duccio Volterrani, Steven M. Larson, 2012-11-27 This book provides the reader with a comprehensive understanding of both the basic principles and the clinical applications of nuclear oncology imaging techniques. The authors have assembled a distinguished group of leaders in the field who provide valuable insight on the subject. The book also includes major chapters on the cancer patient and the pathophysiology of abnormal tissue, the evaluation of co-existing disease, and the diagnosis and therapy of specific tumors using functional imaging studies. Each chapter is heavily illustrated to assist the reader in understanding the clinical role of nuclear oncology in cancer disease therapy and management. |
| anti gd2 therapy neuroblastoma: The EBMT/EHA CAR-T Cell Handbook Nicolaus Kröger, John Gribben, Christian Chabannon, Ibrahim Yakoub-Agha, Hermann Einsele, 2022-02-07 This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA), covers several aspects of CAR-T cell treatments, including the underlying biology, indications, management of side-effects, access and manufacturing issues. This book, written by leading experts in the field to enhance readers’ knowledge and practice skills, provides an unparalleled overview of the CAR-T cell technology and its application in clinical care, to enhance readers’ knowledge and practice skills. |
| anti gd2 therapy neuroblastoma: Pediatric Neuro-oncology Katrin Scheinemann, Eric Bouffet, 2015-03-26 “The editors...have done an outstanding job of presenting...complex information in a lucid manner – this book is a must-read for the global community of aspiring students and neuro-oncology practitioners.” Amar Gajjar, MD in the Foreword This is a succinct introduction to pediatric neuro-oncology. It summarizes the key advances in molecular biology that have helped transform this rapidly evolving field and provides up-to-date coverage of major and emerging treatment modalities as well as supportive care. Separate chapters present each kind of pediatric brain cancer and its diagnosis and treatment. As more children survive brain cancer, the importance of quality of life issues and helping survivors to cope with the neuropsychological impact and long-term effects of current therapies has come into sharper focus; these topics are also addressed in the book, as are palliative care and pediatric neuro-oncology in countries with limited resources. The book is aimed at trainees and practitioners who seek an up-to-date text in pediatric neuro-oncology that is both comprehensive and concise. |
| anti gd2 therapy neuroblastoma: Essentials of Glycobiology Ajit Varki, Maarten J. Chrispeels, 1999 Sugar chains (glycans) are often attached to proteins and lipids and have multiple roles in the organization and function of all organisms. Essentials of Glycobiology describes their biogenesis and function and offers a useful gateway to the understanding of glycans. |
| anti gd2 therapy neuroblastoma: Handbook of Glycosyltransferases and Related Genes Naoyuki Taniguchi, Koichi Honke, Minoru Fukuda, 2011-06-28 The so-called postgenomic research era has now been launched, and the field of gly cobiology and glycotechnology has become one of the most important areas in life science because glycosylation is the most common post-translational modification reaction of proteins in vivo. On the basis of Swiss-Prot data, over 50% proteins are known to undergo glycosylation, but in fact the actual functions of most of the sugar chains in the glycoconjugates remain unknown. The complex carbohydrate chains of glycoproteins, glycolipids, and proteoglycans represent the secondary gene products formed through the reactions of glycosyl transferases. The regulation of the biosynthesis of sugar chains is under the control of the expression of glycosyltransferases, their substrate specificity, and their local ization in specific tissue sites. There is a growing body of evidence to suggest that these enzymes play pivotal roles in a variety of important cellular differentiation and developmental events, as well as in disease processes. Over 300 glycosyltransferases appear to exist in mammalian tissues. If the genes that have been purified and cloned from various species such as humans, cattle, pigs, rats and mice are counted as one, approximately 110 glycogenes that encode glycosyltransferases and related genes have been cloned at present, and this number continues to grow each day. However, most of the functions of the glycosyltransferase genes and related genes are unknown. This fact has stimulated numerous new and interesting approaches in molecular biologi cal investigations. |
| anti gd2 therapy neuroblastoma: Childhood Cancer and Functional Impacts Across the Care Continuum National Academies of Sciences Engineering and Medicine, Health and Medicine Division, Board on Health Care Services, Committee on Childhood Cancers and Disability, 2021-09-09 Since the late 1960s, the survival rate in children and adolescents diagnosed with cancer has steadily improved, with a corresponding decline in the cancer-specific death rate. Although the improvements in survival are encouraging, they have come at the cost of acute, chronic, and late adverse effects precipitated by the toxicities associated with the individual or combined use of different types of treatment (e.g., surgery, radiation, chemotherapy). In some cases, the impairments resulting from cancer and its treatment are severe enough to qualify a child for U.S. Social Security Administration disability benefits. At the request of Social Security Administration, Childhood Cancer and Functional Impacts Across the Care Continuum provides current information and findings and conclusions regarding the diagnosis, treatment, and prognosis of selected childhood cancers, including different types of malignant solid tumors, and the effect of those cancers on childrenâ (TM)s health and functional capacity, including the relative levels of functional limitation typically associated with the cancers and their treatment. This report also provides a summary of selected treatments currently being studied in clinical trials and identifies any limitations on the availability of these treatments, such as whether treatments are available only in certain geographic areas. |
| anti gd2 therapy neuroblastoma: Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer Treatment National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, 2016-12-10 Immunotherapy is a form of cancer therapy that harnesses the body's immune system to destroy cancer cells. In recent years, immunotherapies have been developed for several cancers, including advanced melanoma, lung cancer, and kidney cancer. In some patients with metastatic cancers who have not responded well to other treatments, immunotherapy treatment has resulted in complete and durable responses. Given these promising findings, it is hoped that continued immunotherapy research and development will produce better cancer treatments that improve patient outcomes. With this promise, however, there is also recognition that the clinical and biological landscape for immunotherapies is novel and not yet well understood. For example, adverse events with immunotherapy treatment are quite different from those experienced with other types of cancer therapy. Similarly, immunotherapy dosing, therapeutic responses, and response time lines are also markedly different from other cancer therapies. To examine these challenges and explore strategies to overcome them, the National Academies of Sciences, Engineering, and Medicine held a workshop in February and March of 2016. This report summarizes the presentations and discussions from the workshop. |
| anti gd2 therapy neuroblastoma: The American Cancer Society's Oncology in Practice The American Cancer Society, 2018-05-01 Developed by the American Cancer Society this new textbook designed for a wide range of learners and practitioners comprehensively addresses all aspects of clinical management for cancer taking a balanced, authoritative and, -where possible- evidence-based stance and may be used in conjunction with the book, The American Cancer Society's Principles of Oncology: Prevention to Survivorship. Edited by leading clinicians in the field and a stellar contributor list from the US and Europe, this book is written in an easy to understand style by multidisciplinary teams of medical oncologists, radiation oncologists and other specialists, reflecting day-to-day decision-making and clinical practice. Input from pathologists, surgeons, radiologists, and other specialists is included wherever relevant and comprehensive treatment guidelines are provided by expert contributors where there is no standard recognized treatment. This book is an ideal resource for anyone seeking a practical understanding of the field of oncology. |
| anti gd2 therapy neuroblastoma: Nuclear Oncology Cumali Aktolun, Stanley Goldsmith, 2014-09-04 Nuclear Oncology a contemporary narrative of the role of nuclear medicine in oncology with an emphasis on SPECT/CT and PET/CT with additional comments when appropriate on the potential application of PET/MR and to a lesser degree, targeted radionuclide therapy. This book focuses on the use of radionuclides in the diagnosis and treatment of malignant diseases. It describes relevant approved and investigational clinical applications, instrumentation & technology, chemistry and practical clinical issues in nuclear oncology. The basic science and current research topics of nuclear oncology are addressed in separate chapters. Nuclear medicine has become an essential component to all phases of the management of the patient with a malignant tumor and in some cases, even benign neoplasms. The standard of practice for many tumors requires PET/CT imaging at various stages of diagnosis and management. In addition to clinical applications, ongoing investigational efforts, which more and more involve multi-institutional protocols, are also presented. Features: • Focuses on the use of radionuclides in the diagnosis and treatment of malignant diseases • Emphasizes SPECT/CT and PET/CT with additional emphasis on the potential application of PET/MR • Describes relevant approved and investigational clinical applications, instrumentation & technology, chemistry and practical clinical issues in nuclear oncology |
| anti gd2 therapy neuroblastoma: Encyclopedia of Cancer , 2018-10-12 Encyclopedia of Cancer, Third Edition, Three Volume Set provides a comprehensive, up-to-date overview of the multiple facets of the disease, including research, treatment and societal impact. This new edition comprises 180 contributions from renown experts who present the latest in Mechanisms, Hallmarks of Cancer, Causes of Cancer, Prevention and Control, Diagnosis and Therapy, Pathology and the Genetics of specific Cancers. Readers will find a comprehensive overview of the main areas of oncology, including etiology, mechanisms, prevention, and treatments, from basic science to clinical applications and public health, all set alongside the latest advances and hot topics that have emerged since the previous edition. Topics of interest in the field, including genomics and epigenomics, our understanding of the causes of cancer and the approaches to preventing it (e.g., HPV vaccination, role of obesity and nutrition, molecular markers of environmental exposures), new screening techniques (e.g., low-dose CT for lung cancer) and improvements in the treatment of many cancers (e.g., breast cancer, lung adenocarcinoma) are comprehensively and authoritatively presented. Comprises 180 contributions from renowned experts who present the latest in mechanisms, hallmarks of cancer, causes, prevention and control, diagnosis and therapy, pathology and genetics Presents a comprehensive overview of the main areas of oncology, including etiology, mechanisms, prevention, and treatments, from basic science to clinical applications and public health |
| anti gd2 therapy neuroblastoma: Pediatric Lymphomas Howard J. Weinstein, Melissa M. Hudson, Michael P. Link, 2007-01-20 This is a comprehensive textbook of Hodgkin's and non-Hodgkin's lymphomas written by leaders in the field of childhood lymphomas. It includes clinical, pathologic and molecular biology of each subtype of lymphoma. The pathology chapters are comprehensive and include excellent photographs. The book is at the level of subspecialists in pediatric hematology and oncology, radiation oncology, pediatric surgery and hematopathology. |
| anti gd2 therapy neuroblastoma: Biosimilars of Monoclonal Antibodies Cheng Liu, K. John Morrow, Jr., 2016-12-09 Addressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all aspects of biosimilar development: preclinical, clinical, regulatory, manufacturing. • Guides readers through the complex landscape involved with developing biosimilar versions of monoclonal antibody (mAb) drugs • Features flow charts, tables, and figures that clearly illustrate processes and makes the book comprehensible and accessible • Includes a review of FDA-approved mAb drugs as a quick reference to facts and useful information • Examines new technologies and strategies for improving biosimilar mAbs |
| anti gd2 therapy neuroblastoma: Drug-Induced Liver Injury , 2019-07-13 Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. - Includes the authority and expertise of leading contributors in pharmacology - Presents the latest release in the Advances in Pharmacology series |
| anti gd2 therapy neuroblastoma: Role of Nutraceuticals in Cancer Chemosensitization , 2017-10-18 Role of Nutraceuticals in Chemoresistance to Cancer, Volume Two, focuses on nutraceuticals, the compounds derived from natural sources, which are usually multi-targeted as a means to overcome chemoresistance. This book discusses the role of several compounds related to nutraceuticals and chemoresistance, such as curcumin, resveratrol, indole 3-carbinol, tocotrienols, ursolic acid, fisetin, celastrol, gambogic, butein, catechins and silymarin. It is a valuable resource for cancer researchers, oncologists and members of several areas of the biomedical field who are interested in understanding how to use nutraceuticals as a sensitizing agent for chemotherapy. - Brings updated information on natural compounds used as specific inhibitors of cell signaling pathways as reviewed by experts in the field - Presents experts analysis and summary of reported and novel findings and potential translational application in cancer patients - Describes molecular mechanisms with new and helpful approaches for the readers to use in their own investigations |
| anti gd2 therapy neuroblastoma: EBMT HANDBOOK , 2025 |
| anti gd2 therapy neuroblastoma: Immunologic Concepts in Transfusion Medicine Robert W Maitta, 2019-08-27 Immunological Concepts in Transfusion Medicine provides a thorough discussion of the immune aspects of blood component transfusion, with in-depth information on the intricacies of immune responses to blood components and the immune processes that may be initiated in response to blood exposure. Written to increase knowledge and awareness of immune challenges such as alloimmunization and transfusion-related acute lung injury, this title bridges current basic scientific discoveries and the potential effects seen in blood recipients. - Complies the knowledge and expertise of Dr. Robert Maitta, an expert in immune responses and antibody function/structure studies. - Helps clinicians in the daily practice of caring for patients in need of transfusion support, as well as physicians in training when considering utilizing blood transfusions in a limited scope or in the setting of massive transfusion. - Includes an immunology primer as an introduction to in-depth chapters covering allergic immune reactions to blood components, transfusion-related immunomodulation, fetal and neonatal alloimmune thrombocytopenia and neonatal neuthropenia, complications of haploidentical and mismatched HSC transplantation, chimeric antibody receptor therapies, and much more. - Consolidates today's available information on this timely topic into a single, convenient resource. |
| anti gd2 therapy neuroblastoma: Bone Marrow Environment Marion Espéli, Karl Balabanian, 2021-06-01 This volume brings together classical and cutting-edge protocols on the spatio-temporal study of the cellular subsets constituting the bone and the marrow in both mouse and human. Chapters details methods on bone marrow (BM) ecosystem, to label, sort, analyse, and culture specific cell subsets as well as techniques allowing the evaluation of the function of some of the cellular elements of the BM. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Bone Marrow Environment: Methods and Protocols aims to help new investigators to pursue the characterization of the BM microenvironment in the coming years. |
| anti gd2 therapy neuroblastoma: Chimeric Antigen Receptor T-Cell Therapies for Cancer E-Book Daniel W. Lee, Nirali N. Shah, 2019-11-30 From patient referral to post-therapy management, Chimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer: A Practical Guide presents a comprehensive view of CAR modified T-cells in a concise and practical format. Providing authoritative guidance on the implementation and management of CAR T-cell therapy from Drs. Daniel W. Lee and Nirali N. Shah, this clinical resource keeps you up to date on the latest developments in this rapidly evolving area. - Covers all clinical aspects, including patient referral, toxicities management, comorbidities, bridging therapy, post-CAR monitoring, and multidisciplinary approaches to supportive care. - Includes key topics on associated toxicities such as predictive biomarkers, infections, and multidisciplinary approaches to supportive care. - Presents current knowledge on FDA approved CAR T-cell products as well as developments on the horizon. - Editors and authors represent leading investigators in academia and worldwide pioneers of CAR therapy. |
| anti gd2 therapy neuroblastoma: Individuality in music performance Bruno Gingras, 2014-10-22 Humans are remarkably adept at identifying individuals on the basis of their facial features, or other traits such as gait or vocal timbre. Besides voice, another auditory medium capable of carrying identity information is music. Indeed, certain famous musicians, such as John Coltrane or Sonny Rollins, need only to play a few notes to be unequivocally recognized. Along with emotion and structural cues, artistic individuality seems to be a key element communicated in music performance. Yet, the means by which individuality is expressed in performance, as well as the cognitive processes employed by listeners to perceive identity cues, remain poorly elucidated. Other pertinent issues, including the connection between a performer’s technical competence and ability to convey a specific musical identity, as well as potential links between individuality and career-defining outcomes such as critical recognition and aesthetic appraisal, warrant further exploration. Quantitative approaches to the study of music performance have benefited greatly from MIDI technology and the application of computational methods, leading to the flourishing of empirical music performance research over the last few decades. More recently, neuroimaging techniques have provided valuable insights into the neural mechanisms involved in the cognitive processes of performing music. Nevertheless, this field continues to benefit greatly from qualitative approaches, given that the communication of affect and identity cues in music performance leads to a rich subjectivity of impressions that must be accounted for in order to lead to a greater understanding of this multifaceted phenomenon. The aim of this Research Topic is to provide a forum for interdisciplinary research broadly related to the expression and perception of individuality in music performance. Research methodology includes behavioral, psychophysiological, and neuroimaging techniques. Both quantitative and qualitative approaches are presented The scope of this Research Topic includes laboratory studies as well as studies in real-life performance settings and longitudinal studies on performers. |
| anti gd2 therapy neuroblastoma: Comprehensive Glycoscience G.-J. Boons, Y. C. Lee, A. Suzuki, N. Taniguchi, A.G.J. Voragen, 2007-08-21 Carbohydrates are an important part of life and are present in bacteria, fungi, viruses, yeast, plants, animals and humans. The rapid expansion of chemistry and glycobiology over the last few years has provided many new, imaginative and efficient techniques which provide further insight into the structures and biological interactions of carbohydrates and glycostructures. Comprehensive Glycoscience has a very broad scope and will appeal to a wide audience as it explores the interactions between biology, chemistry and molecular biology towards understanding, synthesising and developing glycoproteins, glycolipids, proteoglyans and polysaccharides, which are important molecules in nature for controlling health and disease and food and feed. Glycocompounds reviewed include: oligosaccharides, polysaccharides, glycoproteins, glycolipids, glycoconjugates, lectins, cellulose, pectins and starch. Topics covered include: spectroscopy, nomenclature, structures, synthesis, biosynthesis, molecular interactions, degradation, biochemistry, glycobiology, glycotherapeutics and diseases. Combines multiple aspects of glycoscience in one comprehensive work Documents the new and rapid expansion of carbohydrate chemistry and glycobiology over the last few years Highlights the many new, imaginative and efficient techniques for providing insights into carbohydrates and glycostructures |
| anti gd2 therapy neuroblastoma: Martindale Sean C. Sweetman, 2006-01-01 This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced |
| anti gd2 therapy neuroblastoma: Pediatric Surgical Oncology Paul D. Losty, Michael La Quaglia, Sabine Sarnacki, Jörg Fuchs, Tomoaki Taguchi, 2022-02-17 A new, definitive, state-of-the-art reference in the specialist field of paediatric surgical oncology. Key points and informative guidance on all aspects of cancer surgery for children make this a vital textbook for the surgery resident, surgical oncology specialist, nursing staff and cancer health care teams. The editorial team of world experts and international guest authorship listings guarantees that the textbook content provides a definitive treatise for a global audience of pediatric surgeons. Textbook coverage includes chapters on pediatric cancer epidemiology, chemotherapy, immunotherapy, radiotherapy, pathology, radiology and vascular access, following which the main theme sections feature all of the major pediatric solid tumours in a system-based chronology. A section devoted to rare tumours provides useful and pragmatic information for the oncology surgeon. Minimally invasive surgery is covered highlighting current concepts and clinical outcome(s) by leading experts in the field. Nutritional considerations for the pediatric cancer patient undergoing surgery are all discussed. Management of surgical complications, fertility considerations and long-term outcomes are an invaluable vital resource for the reader. Final sections look to the future by focusing on surgical innovation, including key chapters on navigational surgery and surgical robotics. • Includes all the latest developments in pediatric surgical oncology ensuring the reader is kept fully up to date. • Multi-disciplinary content reflects current best practice. • Comprehensive coverage provides a definitive reference guide. An authoritative seminal reference work for surgical residents in training, surgeons working in the field of pediatric oncology, medical oncologists, intensive care specialists, nursing staff and allied health care professionals. |
| anti gd2 therapy neuroblastoma: Clinical Nuclear Medicine Hans-Jürgen Biersack, Leonard M. Freeman, 2008-01-03 This work has true international scope, being a unique European/American joint venture that focuses on the state of the art in both diagnostic and therapeutic radionuclide methodology. Pertinent clinical applications are emphasized rather than attempting to cover everything included in the several large comprehensive texts available in our field. This practical approach should make it an essential guide to nuclear medicine physicians, technologists, students and interested clinicians alike. |
| anti gd2 therapy neuroblastoma: Psychosocial Aspects of Chemotherapy in Cancer Care Robert DeBellis, 1987 Leading medical professionals--physicians, nurses, social workers--who treat cancer patients receiving chemotherapy address vital areas of concern: physician/patient relationships, the psychosocial issues of being a patient, the pediatric patient, and new frontiers. Valuable and readable for health professionals and cancer patients and their families, this book deals honestly with the relevant, often painful subjects inherent in the diagnosis and treatment of cancer with chemotherapy. Contributing authors emphasize the importance of establishing a positive, trusting relationship between patient and doctor and patient's family and of treating the psychologican and social aspects of patients, as well as the medical problems. The eleven patients'rights described in one chapter should be available to all cancer patients and their families who are faced with the decision of choosing chemotherapy as the course of treatment. The problems particular to treating pediatric patients are examined, along with sound advice for school personnel in dealing with cancer patients in the classroom. |
| anti gd2 therapy neuroblastoma: Advances in Cancer Biomarkers Roberto Scatena, 2015 At present there are a growing number of biomolecules under investigation to understand their potential role as cancer biomarker for diagnostic, prognostic and therapeutic purposes. Intriguingly, the state of art on cancer biomarkers research shows interesting and promising results together to clamorous failures. Also from a clinical point of view, there are contradictory results on routine clinical use of the present cancer biomarkers. Some patients may be simply monitored in their course by a periodic blood sample, but sometimes this monitoring shows dramatic limits. A lot of patients show serious and extensive relapses without significant change in serum concentrations of biomarkers tested. Often the physician who should utilize these biomarker does not entirely know their limits and the total potential applications as well and sometimes this knowledge is influenced by economical and marketing strategies. This limited and polluted knowledge may have dramatic consequences for patient. The aim of this book is to diffuse all aspects of cancer biomarkers, from their biochemical peculiarities to all clinical implications by passing through their physiology and pathophysiology. This critical approach towards old and new cancer biomarkers should foster a deepened and useful understanding of the diagnostic and prognostic index of these fundamental parameters of laboratory medicine and in the same time facilitating the research of new and more sensitive-specific signals of the cancer cell proliferation. |
| anti gd2 therapy neuroblastoma: Cancer Registration Ole Møller Jensen, 1991 Data obtained by population based cancer registries have a pivotal role in cancer control. Now also available in Spanish and French, this volume, which contains 15 authored chapters and four useful appendices, remains a standard reference for those planning to establish new cancer registries and those keen to adopt recognized methodologies. Information is given on the techniques required to collect, store, analyse and interpret data. |
| anti gd2 therapy neuroblastoma: Bone Marrow Niche Takashi Nagasawa, 2021-12-01 This volume summarizes recent advances in research on mesenchymal cell populations in the bone marrow. It explores how mesenchymal cells create niches for immune cells in extramedullary organs and it discusses new concepts of lympho-hematopoietic microenvironments. Readers are introduced to the fundamentals of hematopoietic stem cells (HSCs) differentiation to all types of blood cells, including immune cells, in the bone marrow. The book highlights how this process is supported and regulated by the individual microenvironments of stem cells, termed niches. The identity of HSC niches has been subject to longstanding debates. Recent studies identified the population of mesenchymal stem cells as the major cellular component of niches, for hematopoietic stem and progenitor cells (HSPCs) and their candidate developmental origin. Furthermore, candidate cellular niches for immune cells in lymph nodes and adipose and connective tissues were identified. The authors of this volume focus on shared features between those and HSPC niche cells in the bone marrow. Covering latest research results, this book serves as fascinating read for researchers and clinicians in hematology and immunology. |
| anti gd2 therapy neuroblastoma: Intercellular Communication in Cancer Mustapha Kandouz, 2015-11-20 Cells are by nature compelled to live in groups. They develop dependence over signaling cues received from their microenvironment, in particular from other cells, whether of their own “kind” or of a different type. Therefore, communicating with these cells is a critical aspect of their behavior and fate, as they live and die normally or as they undergo disease-related pathological changes, with dramatic repercussions. In this book, we have asked expert researchers in the field of Intercellular Communication in Cancer to provide chapters on different aspects of interaction between neighboring cells, in the context of cancer diseases. We have specifically focused our efforts on membrane-to-membrane contact-based rather than growth factors-mediated modes of intercellular communications. The contributing authors provide an extensive overview of their respective area of specialization, with an in-depth discussion of the molecular mechanisms of cell-cell interactions, the impact on tumor progression and response to therapies, as well as the cancer diagnostic value of this scientific information. This book aims to introduce essential aspects of the normal and pathological cellular fate and homeostasis to both scientists and clinicians, and also to provide established researchers with an update on the novelties and future directions this expanding field is witnessing. |
| anti gd2 therapy neuroblastoma: Sialic Acids, Part II: Biological and Biomedical Aspects David C. Baker, 2019-03-07 Sialic Acids, Volume 76, the most recent release in the Advances in Carbohydrate Chemistry and Biochemistry series, is the second volume of a two-volume set devoted to the sialic acids. Vol. 76, devoted to the biological and biomedical aspects of sialic acids, includes chapters on Sialic Acids in Neurology, Sialic Acids in Nonenveloped Virus Infections, and The Biology of Gangliosides, all written by leading experts in their fields. - Features contributions from leading authorities and industry experts who specialize in carbohydrate chemistry, biochemistry and research - Integrates the industrial, analytical and technological aspects of biochemistry, organic chemistry and instrumentation methodology in the study of carbohydrates - Informs and updates on all the latest developments in the field |
| anti gd2 therapy neuroblastoma: Human Neuroblastoma Manfred Schwab, G. P. Tonini, Jean Bénard, 1993 |
| anti gd2 therapy neuroblastoma: Carbohydrate Antigens Per J. Garegg, Alf A. Lindberg, American Chemical Society. Division of Carbohydrate Chemistry, 1993 Developed from a symposium at the Fourth Chemical Congress of North America (202nd National Meeting of the ACS) in New York City, August 1991, chapter-papers present research on topics including how proteins recognize and bind oligosaccharides, synthesis and immunological properties of glycopeptide T-cell determinants, Vibrio cholerae polysaccharide studies, and purification of oligosaccharide antigens by weak affinity chromatography. Annotation copyright by Book News, Inc., Portland, OR |
Download Free Antivirus for Windows 10 PCs & Laptops | Avast
I had recommended Avast™ to a co-working friend because he said his computer was running slow. He said he ran the anti-virus twice and his computer speed improved.
Download Free Antivirus Software | Avast 2025 PC Protection
While it’ll keep your computer relatively safe against most types of malware, its anti-phishing protection is limited to Microsoft Edge — so you’ll need Avast Free Antivirus to protect you on …
Download Free Antivirus Software for Windows 11 | Avast
Strengthen your Windows 11 PC security and protect your entire home Wi-Fi network, plus get advanced tools like anti-malware security, Wi-Fi security scans, and more — all completely free.
Avast | Download Free Antivirus & VPN | 100% Free & Easy
Join 435 million others and get award-winning free antivirus for PC, Mac & Android. Surf safely & privately with our VPN. Download Avast today!
Avast | Download Free Antivirus & VPN | 100% Free & Easy
Join hundreds of millions of others & get free antivirus for PC, Mac, & Android. Surf safely with our VPN. Download Avast!
Télécharger antivirus gratuit | Protection Avast 2025 pour PC
Agent anti-ransomwares Protégez mieux vos informations personnelles. Ne laissez pas vos documents personnels (photos, fichiers…) devenir l’otage d’un ransomware.
Anti-Tracking Software | Download Avast AntiTrack
Anti-tracking software alone doesn’t protect you against malware and viruses. It’s designed to help block advertisers and trackers from collecting and sharing your data. In addition, anti …
The Best Free Antivirus Software for Windows in 2025 - Avast
Feb 2, 2022 · Core protection capabilities: While PCMag highlights Windows Defender’s strong performance in anti-malware tests, they found the program’s anti-phishing protections lacking. …
Avast Offline Installation Files | Avast
For small businesses and home office we recommend using our Avast Business Security and Antivirus installation file, for unmanaged solutions. For managed solutions, please use the …
Free Virus Scanner | Virus Scan & Removal Software - Avast
Windows Defender lacks many essential features that other free antivirus security solutions provide, such as offline protection and comprehensive anti-phishing defenses. Instead of …
Download Free Antivirus for Windows 10 PCs & Laptops | Avast
I had recommended Avast™ to a co-working friend because he said his computer was running slow. He said he ran the anti-virus twice and his computer speed improved.
Download Free Antivirus Software | Avast 2025 PC Protection
While it’ll keep your computer relatively safe against most types of malware, its anti-phishing protection is limited to Microsoft Edge — so you’ll need Avast Free Antivirus to protect you on …
Download Free Antivirus Software for Windows 11 | Avast
Strengthen your Windows 11 PC security and protect your entire home Wi-Fi network, plus get advanced tools like anti-malware security, Wi-Fi security scans, and more — all completely free.
Avast | Download Free Antivirus & VPN | 100% Free & Easy
Join 435 million others and get award-winning free antivirus for PC, Mac & Android. Surf safely & privately with our VPN. Download Avast today!
Avast | Download Free Antivirus & VPN | 100% Free & Easy
Join hundreds of millions of others & get free antivirus for PC, Mac, & Android. Surf safely with our VPN. Download Avast!
Télécharger antivirus gratuit | Protection Avast 2025 pour PC
Agent anti-ransomwares Protégez mieux vos informations personnelles. Ne laissez pas vos documents personnels (photos, fichiers…) devenir l’otage d’un ransomware.
Anti-Tracking Software | Download Avast AntiTrack
Anti-tracking software alone doesn’t protect you against malware and viruses. It’s designed to help block advertisers and trackers from collecting and sharing your data. In addition, anti …
The Best Free Antivirus Software for Windows in 2025 - Avast
Feb 2, 2022 · Core protection capabilities: While PCMag highlights Windows Defender’s strong performance in anti-malware tests, they found the program’s anti-phishing protections lacking. …
Avast Offline Installation Files | Avast
For small businesses and home office we recommend using our Avast Business Security and Antivirus installation file, for unmanaged solutions. For managed solutions, please use the …
Free Virus Scanner | Virus Scan & Removal Software - Avast
Windows Defender lacks many essential features that other free antivirus security solutions provide, such as offline protection and comprehensive anti-phishing defenses. Instead of …
